LEFOL LAMIRA is a biologically active form of folic acid
Folate is needed by everyone to divide cells and inactivate toxic metabolic products.
Modern man does not have enough folate in his diet. And for the assimilation of synthetic folic acid “from the pharmacy” you need a full-fledged MTHFR gene. It encodes an enzyme that converts folic acid to biologically active L-methylfolate. 62% of people cannot digest ordinary folic acid on their own for genetic reasons.
Taking the drug Lefol avoids problems with absorption. The key advantage of L-methylfolate is the direct intake of the substance in the active form, even in the case of problems with genetics. L-methylfolate is a 100% biological effect.
Folate deficiency is especially dangerous for the body of a pregnant woman due to miscarriage, frozen pregnancy, placental abruption, preeclampsia. Mothers with folate absorption problems often have miscarriages and children are born with malformations (hydrocephalus, anencephaly, cerebral hernia, hare’s lip or wolf’s mouth, neural tube defects, spina bifida, heart and vascular malformations).
Folic acid deficiency can lead to heart attack, stroke, oncology, anemia. Folic acid is needed for the balance of neurotransmitters in the nervous system. Norepinephrine helps maintain vitality, and serotonin provides healthy sleep and mood. Folate deficiency is also manifested by deterioration of the skin, ulcers on the mucous membranes, digestive disorders and frequent intestinal infections.
Lefol in preparation for pregnancy and in the first trimester, as well as for prophylactic purposes is used in a dose of 1-2 tablets per day. In diseases caused by folate deficiency, the scheme is determined by a doctor.
The company D & D Pharmaceutical is a unique, accredited, licensed representative of products Lamyra, in Ukraine.